Herb Profile

Bupleurum Falcatum

Bupleurum falcatum

Bupleurum falcatum is an herb historically used in traditional East Asian medicine, containing active compounds like Saikosaponin A.

Last reviewed: 3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution Hepatobiliary active potential; use caution with liver disease, gallbladder disease, bile duct obstruction, hepatotoxic drugs, and pregnancy. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Liver Protective, Anti Inflammatory, Inflammatory signaling, Digestive support
Avoid / review if
Pregnancy/Breastfeeding Without Clinician Supervision, Known Allergy To The Plant/Family, Active Liver Disease
Bupleurum Falcatum monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Hepatobiliary-active potential; use caution with liver disease, gallbladder disease, bile-duct obstruction, hepatotoxic drugs, and pregnancy.
Profile context
liver-protective, anti-inflammatory
Next steps

Continue reading

  • If you want to browse more herbsAll herbs

Safety

Safety & Cautions

Hepatobiliary active potential; use caution with liver disease, gallbladder disease, bile duct obstruction, hepatotoxic drugs, and pregnancy.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Liver-SensitiveLiver-related caution language appears in the profile.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Pregnancy/Breastfeeding Without Clinician Supervision
  • Known Allergy To The Plant/Family
  • Active Liver Disease
  • Potential Interaction Concern With Immunosuppressants
  • Use Clinician Review For High Dose Extracts Or Chronic Use.

Safety classifications

  • Interaction-Aware: Medication or interaction context is explicitly noted.
  • Liver-Sensitive: Liver-related caution language appears in the profile.
  • Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

  • Hepatobiliary active potential; use caution with liver disease, gallbladder disease, bile duct obstruction, hepatotoxic drugs, and pregnancy.

Safety labels

  • Interaction-Aware
  • Liver-Sensitive
  • Pregnancy/Breastfeeding Caution

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedInflammatory Signaling Modulation · NF KB Modulation

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableHepatobiliary active potential; use caution with liver disease, gallbladder disease, bile duct obstruction, hepatotoxic drugs, and pregnancy.

This profile cites 3 human studies.

How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (3)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

What the evidence actually shows

This table contains 3 structured sources, including 0 human evidence sources; 0 are human trials. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.

Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned

What would change our conclusion?

Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB

Park WH et al. · J Ethnopharmacol · 2015

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Bupleurum falcatum prevents depression and anxiety-like behaviors in rats exposed to repeated restraint stress

Lee B et al. · J Microbiol Biotechnol · 2012

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Suppressing effect of a saikosaponin-enriched extract of Bupleurum falcatum on alcohol and chocolate self-administration in rats

Maccioni P et al. · Nat Prod Res · 2022

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Preparation varies by tradition and product form and require source backed dosage review before therapeutic claims.
How Bupleurum Falcatum works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Bupleurum Falcatum Works

How Bupleurum Falcatum WorksBupleurum Falcatum acts on biological target pathways via anti inflammatory, leading to liver protective.Bupleurum FalcatumBiological TargetBiological pathwayAnti InflammatoryLiver ProtectiveObservable outcomeNF KB InhibitionParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways

Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.

  • Inflammatory Signaling Modulation
  • NF KB Modulation

Active Compounds

Key constituents studied in Bupleurum Falcatum, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Bupleurum Falcatum

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Bupleurum Falcatum research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Botanical profile context

How to interpret Bupleurum Falcatum

Bupleurum Falcatum herb profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first… Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.

When reviewing Bupleurum Falcatum, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.

For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.